which markedly increases sensitivity to pain (Moore and Dundee, 1961b, c) , was given in premedication, the incidence of muscle twitchings after injection of a standard dose of methohexitone, rose to a prohibitively high level (Moore and Dundee, 1961a) . This effect was also observed, but to a lesser degree, with hyoscine which also frequently causes an increase in sensitivity to somatic pain (Dundee and Moore, 1961b) . 
Sodium, 5-ethyl-5' (1-methyl butyl) thiobarbiturate
On reviewing the literature on methohexitone, Barron and Dundee (1961) found a lack of agreement concerning the incidence of complications associated with its use. This applied particularly to muscle twitchings and hiccough. Studies by the authors (Dundee and Moore, 1961a, b; Moore and Dundee, 1961a) suggest that the incidence of these complications is markedly affected by the nature of the premedication and that this may explain the discrepancies between the findings of various observers. Premedication with an analgesic drug (pethidine) was found to reduce significantly the incidence of spontaneous muscle movements as compared with the incidence after the use of atropine alone (Dundee and Moore, 1961a) . On the other hand, when promethazine, These observations have been made with premedicant drugs of different chemical composition and, despite the comparable conditions which applied to all the studies, it would seem unwise to draw too definite conclusions from the findings. Unknown interactions between methohexitone and the drugs used in premedication cannot be excluded. More valuable information would be obtained from the use of drugs of one chemical group, which vary only in their side chains and their analgesic activity.
Within the past year, the authors have been investigating the effects of various anaesthetic and premedicant drugs on sensitivity to somatic pain, using the method of analgesimetry described by Dundee and Moore (1960) . The most recent 382 studies show that the phenothiazine derivatives cannot be considered as a homogenous group of drugs in respect to their effect on pain (Moore and Dundee, 1961c 2 Relative analgesic action of the nine phenothiazine derivatives, and pethidine, calculated acording to the method described by Moore and Dundee (1961c) .
studied the effects of premedication with the phenothiazine derivatives (in combination with atropine 0.6 mg) on the course of methohexitone anaesthesia, and have compared the results with those obtained using atropine alone and pethidine with atropine. An attempt has been made to correlate the findings with the chemical composition of the phenothiazine derivatives and with their analgesic action as shown in figure 2.
METHOD OF STUDY
A standard anaesthetic technique was employed for a standard operation throughout this investigation. Details of this have been described by Dundee and Moore (1961a) and are summarized below.
All patients were in good physical condition and underwent the operation of uterine curettage.
Anaesthesia was induced with 2 per cent methohexitone in a dosage of approximately 1.6 mg/kg. Anaesthesia was maintained using a mixture of 75 per cent nitrous oxide in oxygen with a total gas flow of 8 l./min. Intermittent doses of methohexitone were given to control reflex movement of the patient. Apart from occasions when suxamethonium was needed to control abnormal muscle movement, no other drugs were given. Pure oxygen was administered for exactly 1 minute at the end of the operation. All anaesthetics were administered personally by the authors.
Special charts were prepared which facilitated the recording of the following complications during anaesthesia.
1. Excitatory phenomena: tremor or spontaneous involuntary muscle movements. 2. Respiratory upset: cough, hiccough or laryngospasm. 3. Marked respiratory depression. 4. The degree and duration of hypotension following the induction dose. (Time permitted only the recording of systolic blood pressure as estimated by palpation of the radial pulse.) 5. Induction and total dose of methohexitone. Using the scheme described by Dundee and Riding (1960) each administration was graded as follows:
1. Uneventful 2. Slight upset, but not as marked as in grade 3. 3. Serious difficulties making surgery impossible or placing the patient's life in jeopardy (including severe, prolonged hypotension). Two minutes after the end of the operation, the condition of each patient was classed as awake, safe (protective reflexes present) or unsafe (absence of protective reflexes).
Each patient was seen 1 hour after the end of anaesthesia and again at the end of 6 hours when the presence or absence of nausea and vomiting was noted.
Where possible, the anaesthetist was not aware of the nature of the premedication at the time of the administration.
Number of observations.
With the exceptions outlined below, the extent of the trial of each of the phenothiazine derivatives was determined by the method of sequential analysis described by Dundee and Moore (1961b) . The basis of this is as follows:
Previous studies with methohexitone anaesthesia enabled the authors to establish the incidence of excitatory phenomena which was considered to be clinically acceptable, namely, that which was observed with atropine premedication (Dundee and Moore 1961a) . Likewise, it was found that prornethazine 50 mg increased the incidence of this complication to a prohibitive degree (Moore and Dundee, 1961a) . From the findings of these two studies, a sequential plan was drawn ( fig. 3 ) on which each consecutive case was plotted as showing the presence or absence of excitatory phenomena. This plan was constructed so that the effect of the premedicants under study on the incidence of excitatory phenomena could be classed as:
(a) Acceptable: atropine-like incidence.
(b) Unacceptable: promethazine-like incidence. (c) Intermediate and probably worthy of further trial. The maximum number of cases needed to reach a conclusion was 35.
As a further and more stringent test of the overall action of the phenothiazine derivative on the course of anaesthesia, a further plan was drawn. This was based on the incidence of grade 1 anaesthesia with atropine (acceptable) and promethazine 50 mg (unacceptable). This allowed the occurrence of hypotension and other undesirable effects which might be attributable to the pre-anaesthetic medication to be taken into account. As will be seen from figure 3, elimination of a compound by reason of its effect in increasing the incidence of excitatory phenomena following the injection of methohexitone automatically eliminates it by virtue of the low incidence of grade 1 anaesthesia. However, a compound may prove acceptable from the excitatory phenomena point of view and yet be eliminated because of a low incidence of grade 1 anaesthesia due to other causes. The reliability of these plans for use with data obtained at a date later than the control observations has been investigated by Dundee and Moore (1961b) , and reasons for their preference to the more widely used "paired cases" technique of sequential analysis has been presented.
It was planned to use the phenothiazine derivatives in random order, making maximum use of "blind" ampoules early in the trial. Once a drug was rejected either on the basis of a high incidence of excitatory phenomena or a low incidence of grade 1 anaesthesia, it use was to be stopped. However, trials with a satisfactory compound continued until it was accepted by both the criteria set out above, or until it was administered as premedication to 35 patients. Thus, contrary to accepted British standards of justice, one rejection classified a drug as unacceptable while two acceptances were necessary before it was considered suitable for everyday use.
It was necessary, on occasions, to alter standards to suit the drug under study and the exceptions are as follows:
Chlorpromazine 50 mg. This was eliminated after only 9 administrations on account of a high incidence of hypotension. However, since it is a widely used drug, it was felt necessary to study its effect on the incidence of excitatory phenomena and a further 10 patients were given 25-mg doses until its action in this respect was shown to be similar to that of atropine.
Promazine 100 mg, while accepted on the basis of a low incidence of excitatory phenomena, caused a too marked degree of tachycardia in the preoperative period to justify its continued use. A further trial was carried out using a 25-mg dose.
Trimeprazine 25 mg. Two frightening episodes of hypotension occurring before the induction of anaesthesia terminated its use after only 10 administrations.
Prochlorperazjne 25 mg. Postoperative hypotension limited its use to 8 cases but a further complete study was carried out using a dose of 12.5 mg.
Promethazine 10 mg. Although eliminated because of a low incidence of grade 1 anaesthesia after only 20 observations, it was desired to compare its effect on the incidence of excitatory phenomena with that of the 50-mg dose. The trial was therefore continued until a total of 36 observations had been made. Pecazine 50 mg. Its early elimination on grades of anaesthesia after 8 administrations was due almost entirely to the incidence of excitatory phenomena. Because of the relationship which had been observed with other drugs between this incidence and "'antianalgesic" action, the trial was continued until the frequency of this side effect reached the incidence required to class it as "promethazine-like". This was considered justifiable since excitatory phenomena are not as dangerous from the patient's point of view as severe hypotension and abnormal muscle movements can be abolished with a small dose of suxamethonium.
The value of the sequential plan in making it possible to screen a large number of drugs with the minimum number of cases is demonstrated by the fact that in this trial nine phenothiazine derivatives were tested. In eight of these it was possible to come to a definite conclusion with a total of only 296 anaesthetics.
RESULTS
It would be impracticable to show the progress of the trial of each drug on the sequential plans in complete detail and the compromise arrangement depicted in figure 3 is presented, with table II for further guidance. Figure 3 shows the results obtained using chlorpromazine 25-50 mg in detail and shows the points at which the other drugs arrived at the limits of acceptance or rejection, or the final number of observations at which the trial was terminated. In order to demonstrate the superiority of pethidine as a premedication for use with methohexitone, and to verify previous findings on its beneficial effects on the course of anaesthesia, data from recent cases are also included in figure 3 . It should be pointed out that the data for promethazine 50 mg included in this figure are those obtained in an earlier trial of this drug (Moore and Dundee, 1961a) , since it was not felt justifiable to continue its use.
The order of listing the phenothiazine derivatives in table II is the same as that in table I and the relationship between the incidence of excitatory phenomena and the anti-analgesic action is apparent. This will be discussed in more detail later.
In order to validate further comparisons between different phenothiazine derivatives, it is necessary to establish that the observations were carried out on comparable groups of patients. The average age and weight of the patients, the mean duration of the anaesthesia and operative procedures and the average induction dose of methohexitone (mg/kg) in each of the series is shown in table HI. For reasons which will be obvious later, the details of patients receiving 100 and 25 mg of promazine have also been pooled as have the details of patients receiving 50 and 10 mg promethazine. The scatter of induction doses has been calculated only where it is intended to study further the total barbiturate requirements.
The similarity of the groups under study (table ITJ) enables a comparison to be made between tie effects of different forms of premedication. All observations on blood pressure changes relate only to the induction dose. Since this was constant with all premedicants it was possible to compare the deleterious effects of the various phenothiazine derivatives. This also simplifies the analysis of the effects of the phenothiazine derivatives on methohexitone requirements. Although there are small variations in the average duration of anaesthesia and operation with the different drugs, these are of no significance since the total dose of methohexitone was invariably given during the first 5 minutes of the administration.
For clarity of presentation, the literature pertinent to each facet of the action of the selected phenothiazine derivatives on barbiturate narcosis will be discussed as near as possible to the relevant results.
Excitatory phenomena.
The percentage incidence of complications with each of the phenothiazine derivatives is shown in table IV, which also includes control data for atropine 0.6 mg and pethidine 100 mg combined with atropine 0.6 mg. Figure 3 shows that promethazine 10 mg and 50 mg and pecazine 50 mg each increased the incidence of excitatory phenomena in comparison with atropine alone, while the other drugs had no significant effect on the. frequency of this complication. There was no difference between the effect of 100 mg and 25 mg of promazine (0.50 > P > 0.40) or 50 and 10 mg promethazine (0.20 > P > 0.10).
Respiratory upset.
Excluding trimeprazine and trifluperazine, where the numbers are too small for statistical evaluation, none of the phenothiazine derivatives significantly affected the incidence of respiratory upset with methohexitone, as compared with atropine alone. In view of the effect of different phenothiazine derivatives on the incidence of excitatory phenomena, it may be of some importance to record that the difference between the incidence of respiratory complications with atropine and the phenothiazine derivatives more nearly reached accepted levels of significance with promethazine 50 and 10 mg and pecazine 50 mg (0.10 > P > 0.05) than with any of the other drugs. The relationship between analgesia and the incidence of respiratory upset is discussed later. There was no marked difference between Table IV shows that none of the phenothiazine derivatives had any appreciable effect on the respiratory depressant action of 1.6 mg/kg methohexitone.
In a recently published textbook, Foster (1959) claims that the use of promethazine prevents such disturbances as bucking, coughing and spasm during anaesthesia. Previous writers have noted that this drug makes laryngeal reflexes less active (Dinnick, 1954; Hopkin, Hunter and Jones, 1957) ; enables endotracheal tubes to be better tolerated (Harrison, 1955) ; and relieves bronchospasm (Loyn, 1956; Watkinson, 1960) . Hunter (1958) has made similar claims for the action of pecazine. Although endotracheal intubation was not carried out in any of the patients in this study, there was no evidence of a depressant action of the phenothiazine derivatives on respiratory tract reflexes.
In fact, the drug for which most claims have been made proved to be one of the least satisfactory as regards the incidence of coughing and hiccough. It must be remembered that these data were obtained using a barbiturate which is associated with a higher incidence of respiratory upset than thiopentone. A more likely explanation for the findings is the absence of pethidine or pethidine or similar drugs in the premedication. As with many other aspects of the actions of phenothiazine derivatives, beneficial effects have been ascribed to them which may, in fact, be due to the large doses of analgesics with which they are frequently combined.
Hypotension.
Too few patients were premedicated with trimeprazine and trifluperazine to enable conclusions to be drawn from the data. These are excluded from the discussion. The data in table IV are further analyzed in table VI. With the exception of triflupromazine and pecazine, premedication with any of the phenothiazine derivatives increased the extent to which the systolic blood pressure fell after injection of the standard induction dose of methohexitone, compared with the changes observed in patients who received atropine alone. The incidence of patients in whom the fall in pressure did not exceed 20 rnm Hg was not significantly increased by premedication with prochlorperazine 12.5 mg, triflupromazine 20 mg, promethazine 10 mg or pecazine 50 mg, but was increased with the other drugs. The figures for average degree of hypotension and the duration of blood pressure fall are based on too few observations to permit statistical evaluation.
Reduction of the dose of promethazine from 50 to 10 mg decreased the frequency and severity of hypotension during the course of the subsequent anaesthesia. This did not apply with the lower (25-mg) dose of promazine, which produced a slightly greater degree of hypotension than the 100-mg dose. The difference between the effects of the two doses of either drug did not reach the accepted levels of significance.
The data were further analyzed to find if any one particular group of phenothiazine derivatives was more prone to cause hypotension than the others. No relationship could be demonstrated between analgesic action and effect on methohexitone-induced blood pressure falls. This also applied when the compounds with dimethylaminopropyl side chains were grouped together and the effects compared with those of the piperazine side chain drugs (table VI) .
It will be recalled that severe degrees of hypotension were frequently encountered before and after operation in patients who received chlorpromazine 50 mg or prochlorperazine 25 mg. This led to a comparison of the degree and frequency of hypotension in patients premedicated with chlorinated and non-chlorinated phenothiazine derivatives. It was not surprising to find a significant difference between these groups (table VI). Too much importance must not be attached to this finding since this is not a comparison between otherwise identical chlorinated and non-chlorinated phenothiazine derivatives. Furthermore, the nonchlorinated group includes triflupromazine, and since fluorine reduces the toxicity of other compounds, this may have unduly biased the results.
Despite the paucity of observations with chlorpromazine, it was considered worth while to compare the degree and severity of hypotension which followed in patients premedicated with promazine (pooled data for 100-mg and 25-mg doses) and its chlorinated and trifluorinated analogues. The findings, which are set out in table VII show that premedication with triflupromazine is associated with less hypotension during anaesthesia than is premedication with either of the other two compounds. With the small amount of data available, it was not possible to demonstrate any significant difference between the effects of chlorpromazine and promazine.
It would be quite impracticable to discuss all the published work on the hypotensive action of phenothiazine derivatives, even in relation to barbiturate anaesthesia only. Some relevant publications will be briefly reviewed. There seems to be unanimity of opinion as regards the hypotensive action of chlorpromazine (Russell, 1956; Kvisselgaard, 1958) which is present even with small doses (Dripps et al., 1955; Etsten and Li, 1957) . When used in premedication it increases blood pressure falls during thiopentone anaesthesia (Dripps et al., 1955; Dundee, 1958) . The work of Eckenhoff, Helrich and Rolph (1957), Millar (1957) and Bergner and Ma (1960) also showed that promethazine has less hypotensive action than chlorpromazine. Eggers, Corssen and Allen (1959) attribute this difference to a weaker adrenolytic action. They also found that the adrenolytic action of pecazine. is intermediate between that of chlorpromazine and that of promethazine. Several reports suggest that clinical doses of pecazine do not frequently produce hypotension (Mignault, 1957; Williams, 1957; Hooper, 1958) , even when given intravenously during anaesthesia (Kavan et al., 1959) .
In a comparative study of various phenothiazine premedicants prior to thiopentone anaesthesia, Dobkin and Purkin (1960) noted too high an incidence of postinduction hypotension following the use of promazine 25 mg and prochlorperazine 5 mg but negligible effects following promethazine 25 mg. However, Lamphier (1959) observed no cardiovascular upset following the intramuscular injection of prochlorperazine 10 mg. Dobkin (1959) found that perphenazine 5 mg had no effect on blood pressure or pulse rate. This is supported by Phillips et al. (1958) , who found that premedication with perphenazine 5 mg resulted in less hypotension during thiopentone, nitrous oxide and oxygen anaesthesia than did morphine 10 mg. Lear et al. (1959) noted a 14.5 per cent incidence of hypotension following intramuscular injection of 10 to 40-mg doses of triflupTomazine and the frequency increased with age and with the addition of pethidine. This was contrary to the experience of Zeedick (1960) , who observed no hypotension following the use of 20-mg doses.
Most of these findings parallel the authors' experiences as reported here. Considering both the duration and severity of hypotension, it was found that premedication with triflupromazine 20 mg or pecazine 50 mg was more satisfactory than with any of the other phenothiazine derivatives. It must not be forgotten, however, that all the seven remaining drugs significantly increased the hypotensive action of methohexitone.
Grades of anaesthesia.
The classification of grades employed in this study, was described originally by Dundee and Riding (1960) , solely for application to the induction of anaesthesia. In this and similar studies in which the operations have been of a standard type and of short duration, it embraces the whole course of anaesthesia. By virtue of the criteria adopted (q.v.), it reflects on all the complications of the administration and is the final standard by which to judge the overall effect of the premedication. Figure 3 shows that only two of the drugs produced as good or safe operating conditions as atropine alone (namely promazine 25 mg and triflupromazine 20 mg). With these two drugs neither the incidence of excitatory phenomena nor the severity or duration of hypotension was markedly increased. Prochlorperazine 12.5 mg and perphenazine 5 mg were almost as good but with both of these the average duration of hypotension was slightly greater than after atropine.
A useful method for expressing the significance of the frequency of grades of anaesthesia as a single figure, which reflects on the relative merits of the various phenothiazine derivatives as premedication agents is to subtract the percentage incidence of grade 3 anaesthesia from that of grade 1. The results of this calculation are set out below and the drugs are listed in order of merit. The ideal premedication given before the ideal intravenous anaesthetic would give a figure of +100. A combination which gives a negative figure is, by virtue of its method of calculation, unsuitable for routine clinical use. Since the value for pethidine premedication is +71, it would appear that it is to be preferred to any of the phenothiazine derivatives when methohexitone is to be used. When promethazine 50 mg and pethidine 100 mg were combined, Moore and Dundee (1961a) found a distribution of grades of anaesthesia which would give a value of + 32. The present findings suggest that either promazine 25 mg or triflupromazine 20 mg should give better results when combined with pethidine 100 mg. Such a combination might have the benefits of the anti-emetic action of the phenothiazine derivatives and the analgesic properties of pethidine.
Dosage.
There have been many claims that the phenothiazine drugs potentiate the action of the barbiturates. The average total requirements of methohexitone have therefore been analyzed for each form of premedication with which there were sufficient cases to justify a comparison with the atropine and pethidine data. Table VIII shows that, with the exception of promethazine 50 mg and pecazine 50 mg, all the phenothiazine derivatives used in the study reduced the total dosage of methohexitone to a significant degree. Their effect on the frequency of supplementary doses of barbiturate was less marked and this was lowered to a significant degree only by chlorpromazine and promazine 25 mg. Premedication with promethazine 50 mg markedly increased the need for supplementary doses. excitatory phenomena. In the uncomplicated administrations, hyoscine significantly reduced total methohexital requirements but the opposite effect was noted in patients in whom muscle movements occurred. The authors concluded that any potentiating effect hyoscine might have was more than counterbalanced by the frequent necessity for large doses in attempts to control abnormal muscle movements.
It was therefore considered necessary to subdivide the phenothiazine data as described above (table IX) . There was no detectable difference in the average total dosage of methohexitone, after atropine premedication, between patients in whom excitatory phenomena did and did not occur. However, such a difference occurred with most of the phenothiazine derivatives with which there were sufficient cases to make the compari- As found previously, premedication with pethidine reduced the total requirements of methohexitone to a striking degree. None of the phenothiazine derivatives caused a significantly greater average reduction in dosage than pethidine and, as expected, the promethazine and pecazine patients required significantly more barbiturate than those who received analgesic.
In a study of the effect of hyoscine on methohexitone anaesthesia, Dundee and Moore (1961b) noted that, although this premedicant did not result in an overall reduction in total barbiturate dosage as compared with atropine, there was a significant difference in the requirements between the patients who did and did not exhibit son. With those drugs in which an overall reduction in dosage has already been demonstrated this did not occur in patients who exhibited excitatory phenomena. In the absence of excitatory phenomena, this reduction in dosage was very marked except after the use of promethazine and pecazine. With these drugs there was no significant difference from the control, irrespective of the occurrence of excitatory phenomena. Thus, while it is possible to attribute part of the failure to demonstrate an overall reduction in methohexitone requirements after promethazine and pecazine premedication to the very frequent need for high doses to control abnormal muscle movements, this is not the complete explanation. Table X lists the frequency of awake, safe and unsafe patients 2 minutes after the end of anaesthesia. Omitting those series in which the overall requirements of methohexitone were not lower than for atropine (promethazine 50 mg and mepazine 50 mg), this table suggests that the remaining drugs, except perphenazine and triflupromazine prolong barbiturate narcosis.
None of these observations, with the exception of those relating to promethazine and pecazine, are contrary to accepted views. Animal experiments by Courvoisier et al. (1953) , Burn (1954) and Dundee and Scott (1958) demonstrated that chlorpromazine prolonged barbiturate narcosis. Dobkin (1960) demonstrated a prolongation of tbiopentone narcosis by promazine in the dog but he was unable to detect any such effect after prochlorperazine, trifluperazine or pecazine. Although his studies did not include chlorpromazine, he stated in a previous paper that promazine was about half as effective as chlorpromazine in potentiating anaesthetics (Dobkin, 1958) . Clinical observations by Dripps et al. (1955) detected a reduction in thiopentone dosage in patients premedicated with chlorpromazine but they considered this to be an additive effect rather than a true potentiation. Dryberg and Johannsen (1958) found no difference between thiopentone requirements after chlorpromazine 50 mg or morphine 10 mg but they did not compare their data with atropine controls. Contrary to our findings are those of Blundell et al. (1959) and Haselhuhn and Brunson (1959) , who stated that a 20 to 50 per cent reduction in thiopentone requirements occurred after promethazine premedication. The present authors are unable to offer any explanation for the difference in their own results. It cannot be attributed to the use of a different barbiturate, for in an earlier study carried out on identical lines, Moore and Dundee (1961a) could not demonstrate any reduction in thiopentone dosage after promethazine.
Sequelae.
It is not the purpose of this study to investigate the relative anti-emetic properties of the phenothiazine derivatives but the available data will be discussed briefly. found that dilatation of the cervix increased the incidence of postoperative vomiting and/or nausea as compared with patients who only had a curettage. He considers that the difference in his results is probably accounted for by the longer time required for the operation of dilatation and curettage (personal communication). The numbers of cases premedicated with each individual phenothiazine derivative are too small to justify subdivision into the above groups, so the control data have been examined (atropine and pethidine figures; table XT). It was found that they did not agree with Riding's finding, presumably because there was a similar duration of anaesthesia for both operations. The authors felt justified, therefore, in pooling the data from both operations in the phenothiazine series. Table XI demonstrates the very low incidence of nausea or vomiting with each of the drugs studied. When these were pooled together, there was no difference between the incidence with the two types of operation but there was a significant increase in the number of patients who had no emetic sequelae, as compared with atropine (P<0.02) or pethidine (P<0.001).
Although restlessness occurred before the induction of anaesthesia with all drugs, this was not observed after operation. One patient, premedicated with perphenazine 5 mg developed pseudoParkinsonism after operation. Athetoid movements of the hands were noted before anaesthesia, which became worse in the postoperative period. Soluble phenobarbitone 200 mg was given 90 minutes after operation and produced a remission of symptoms. A similar incident has been reported by Robbie (1959) but the authors have not observed it with any other drug. Amnesia was not a feature of any of the administrations.
Hypotension with prochlorperazine, chlorpromazine and trimeprazine has already been referred to, and this necessitated a reduction of dosage with the former two drugs and abandonment of the study of the latter. With the reduced dosage it did not occur in the postoperative period.
DISCUSSION
It has been obvious throughout this investigation that some relationship exists between the analgesic action of the phenothiazine derivatives and their effect on the course of methohexitone anaesthesia. This applies particularly to the incidence of excitatory phenomena and to the total dosage of barbiturate required for the standard operation.
In figure 4 the incidence of excitatory phenomena has been plotted against the analgesic indices. Pethidine is included for comparison. This confirms that the more anti-analgesic drugs are associated with higher incidences of this complication. Grouping the compounds as discussed earlier the overall incidences of excitatory phenomena were found to be as follows: Group 1: some analgesic action 25 per cent. Group 2: mildly anti-analgesic 36 per cent. Group 3: strongly anti-analgesic 69 per cent.
There is a highly significant difference between the incidence with each of the three groups. However, not even with group 1 is the frequency of this complication as low as after the use of pethidine (P<0.001).
It was not possible to demonstrate such a close correlation between the analgesic activity of the phenothiazine derivatives and the incidence of respiratory upset associated with their use in premedication. This complication occurred in 22 per cent of group 1 cases and in 24 per cent in group 2. Both these differed significantly (P<0.01) from the 42 per cent incidence in group 3.
As regards dosage, it was found that the markedly anti-analgesic phenothiazines (promethazine, pecazine) did not decrease the total requirements of methohexitone, compared with the atropine control series, whereas a significant reduction was found after the use of all the other drugs (table Vlil). Even in patients who did not exhibit excitatory phenomena it was not possible to demonstrate a reduction in dosage (table IX) following these two phenothiazine derivatives. In addition they increased the frequency of need for supplementary doses of methohexitone. This suggests the possibility of some antagonism between the phenothiazine derivatives under consideration and the anaesthetic state.
Methohexitone is an ideal drug for studies of this nature, being unique among the intravenous barbiturates in current clinical use in regard to the degree to which the course of anaesthesia can be affected by premedication. Dundee and Moore (1961b) have found that another "anti-analgesic" pre-anaesthetic drug (hyoscine 0.4 mg) has an action qualitatively similar to that of promethazine and pecazine. In unpublished studies a similar effect has been detected after the use of cyclizine 50 mg (analgesia index -0.49).
It would be unjustifiable to assume that these findings apply to thiopentone, with which the incidence of complications is normally much lower than with methohexitone. However, Moore and Dundee (1961a) found that premedication with promethazine 50 mg adversely affected the course of thiopentone anaesthesia in a similar manner but to a lesser extent than methohexitone.
Probably the most important clinical application of the present findings is the demonstration of markedly varying effects following the use of different phenothiazine derivatives. These differences do not seem to be generally appreciated judging by the many reports of "phenothiazine premedication" which do not specify the use of a particular drug. It is well known that minor alterations in the barbiturate nucleus can have a profound effect on clinical action and this work shows that the same applies to the phenothiazine group. While the importance of various radicles attached to the barbiturate ring is fairly well known, this cannot be said for the group under study. Our results suggest that chlorination or fluorination may affect their hypotensive action, but no chemical explanation can be offered for their varying analgesic or anti-analgesic activity.
SUMMARY AND CONCLUSIONS
Previous experiences with methohexitone have shown that both the incidence and severity of side effects following injection are markedly affected by the pre-anaesthetic medication. Analgesic drugs were found to decrease the incidence of spontaneous movement, whereas compounds which increase sensitivity to pain had the opposite effect. However, these observations were made with compounds of widely dissimilar chemical structure and it was felt that a study using drugs with a common nucleus, but which differed in the structure of their side chains and in their analgesic activity would be of value. The phenothiazines are such a group.
Using a standard anaesthetic technique for the operation of dilatation and curettage and determining the optimum number of cases by the method of sequential analysis, it was found that the markedly anti-analgesic phenothiazine derivatives significantly increase the frequency of excitatory phenomena during methohexitone anaesthesia. They have a less marked effect on the frequency of respiratory upset with the same drug.
All the phenothiazine derivatives studied with the exception of triflupromazine and pecazine, increased the hypotensive effect of a standard induction dose of methohexitone. There is suggestive evidence that chlorination increases and fluorination decreases the hypotensive action of the phenothiazine derivatives.
A marked reduction in total dosage of methohexitone required for the standard operation was observed with all the phenothiazine derivatives, excepting those with a marked anti-analgesic action. Premedication with pethidine also significantly reduced total barbiturate requirements.
These findings stress the importance of analgesic premedication before the use of methohexitone and suggest that the phenothiazine derivatives are not the best drugs to use before this barbiturate is injected.
